Aratana Theraptcs
(PETX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,242 | 3,129 | -18,067 | -84,054 | -71,199 |
| Depreciation Amortization | 738 | 493 | 244 | 1,840 | 1,596 |
| Income taxes - deferred | N/A | N/A | N/A | -1,698 | -1,389 |
| Accounts receivable | 45 | 43 | 49 | 281 | 208 |
| Accounts payable and accrued liabilities | 3,712 | 5,874 | 4,978 | -117 | -274 |
| Other Working Capital | 3,521 | 10,645 | 2,041 | -156 | -633 |
| Other Operating Activity | 7,474 | 3,103 | -2,654 | 45,409 | 43,587 |
| Operating Cash Flow | $5,248 | $23,287 | $-13,409 | $-38,495 | $-28,104 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -25 | -19 | -6 | -2,245 | -1,856 |
| Purchase Of Investment | -228,840 | -227,346 | -196,399 | -2,050,594 | -1,592,747 |
| Sale Of Investment | 286,793 | 286,046 | 196,847 | 2,086,852 | 1,629,205 |
| Purchase Sale Intangibles | -1,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -1,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $56,928 | $58,681 | $442 | $34,013 | $34,602 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 24,779 | N/A |
| Common Stock Issued | 12,126 | 1 | N/A | 312 | 311 |
| Other Financing Activity | -262 | 0 | 0 | -3,196 | -3,000 |
| Financing Cash Flow | $11,864 | $1 | $N/A | $21,895 | $-2,689 |
| Exchange Rate Effect | 52 | 35 | 26 | -131 | -111 |
| Beginning Cash Position | 27,105 | 27,105 | 27,105 | 9,823 | 9,823 |
| End Cash Position | 101,197 | 109,109 | 14,164 | 27,105 | 13,521 |
| Net Cash Flow | $74,092 | $82,004 | $-12,941 | $17,282 | $3,698 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,248 | 23,287 | -13,409 | -38,495 | -28,104 |
| Capital Expenditure | -25 | -19 | -6 | -2,245 | -1,856 |
| Free Cash Flow | 5,223 | 23,268 | -13,415 | -40,740 | -29,960 |